John Michael Hamm Net Worth

The estimated Net Worth of John M. Hamm is at least $9.18 Thousand dollars as of 23 November 2021. Mr Hamm owns over 3,800 units of Cumberland Pharmaceuticals stock worth over $9,181 and over the last 3 years he sold CPIX stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr Hamm CPIX stock SEC Form 4 insiders trading

Mr has made over 1 trades of the Cumberland Pharmaceuticals stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 3,800 units of CPIX stock worth $8,930 on 23 November 2021.

The largest trade he's ever made was buying 3,800 units of Cumberland Pharmaceuticals stock on 23 November 2021 worth over $8,930. On average, Mr trades about 760 units every 0 days since 2021. As of 23 November 2021 he still owns at least 6,800 units of Cumberland Pharmaceuticals stock.

You can see the complete history of Mr Hamm stock trades at the bottom of the page.

Mr. John Michael Hamm biography

John Michael Hamm is the Director of Fin. & Accounting and CFO at Cumberland Pharmaceuticals.

How old is Mr Hamm?

Mr Hamm is 65, he's been the Director of Fin. & Accounting and CFO of Cumberland Pharmaceuticals since . There are 10 older and 9 younger executives at Cumberland Pharmaceuticals. The oldest executive at Cumberland Pharmaceuticals Inc. is Jonathan Griggs, 85, who is the Independent Director.

What's Mr Hamm's mailing address?

John's mailing address filed with the SEC is 1600 WEST END AVENUE, SUITE 1300, , NASHVILLE, TN, 37203.

Insiders trading at Cumberland Pharmaceuticals

Over the last 15 years, insiders at Cumberland Pharmaceuticals have traded over $4,393,644 worth of Cumberland Pharmaceuticals stock and bought 265,077 units worth $1,208,228 . The most active insiders traders include Joey A Jacobs, Leo Pavliv, and Thomas R Lawrence. On average, Cumberland Pharmaceuticals executives and independent directors trade stock every 29 days with the average trade being worth of $10,407. The most recent stock trade was executed by Caroline Young on 1 December 2022, trading 379 units of CPIX stock currently worth $849.

What does Cumberland Pharmaceuticals do?

cumberland pharmaceuticals is a specialty pharmaceutical company whose mission is to acquire currently marketed and late-stage development pharmaceutical products and grow them through marketing to targeted, underserved physician segments. cumberland is dedicated to providing high quality products which address unmet medical needs.

Complete history of Mr Hamm stock trades at Cumberland Pharmaceuticals

Cumberland Pharmaceuticals executives and stock owners

Cumberland Pharmaceuticals executives and other stock owners filed with the SEC include:

• A. Kazimi,
  Chairman of the Board, Chief Executive Officer
• A. J. Kazimi,
  Founder, Chairman, Pres & CEO
• Leo Pavliv,
  Executive Vice President - Operations, Chief Development Officer
• Leo B. Pavliv,
  Exec. VP of Operations & Chief Devel. Officer
• Martin Cearnal,
  Executive Vice President, Chief Commercial Officer, Director
• Martin E. Cearnal,
  Exec. VP, Chief Commercial Officer & Director
• James Herman,
  Vice President - National Accounts, Chief Compliance Officer
• James Lowrance Herman,
  Sr. VP of National Accounts & Chief Compliance Officer
• Michael Bonner,
  Senior Director Finance and Accounting and Chief Financial Officer
• Caroline Young,
  Independent Director
• Kenneth Krogulski,
  Independent Director
• James Jones,
  Independent Director
• Joey Jacobs,
  Independent Director
• Jonathan Griggs,
  Independent Director
• Joseph Galante,
  Independent Director
• Gordon Bernard,
  Independent Director
• Erin Smith Gull,
  Sr. Corp. Relations Associate
• Adam S. Mostafa,
  Managing Director
• Cindy B. Patton,
  Sr. Director of Field Marketing
• Jean W. Marstiller,
  Sr. VP of Admin. Services & Corp. Sec.
• John Michael Hamm,
  Director of Fin. & Accounting and CFO
• Thomas R Lawrence,
  Director
• Martin S Jr Brown,
  
• Chris T. Bitterman,
  Vice Pres Sales & Marketing
• Rick Scott Greene,
  Chief Financial Officer
• Robert Edwards,
  Director
• Jean W Marstiller,
  Sr. VP & Corp. Secretary
• Lawrence W Greer,
  Director
• David L Lowrance,
  Vice President and CFO
• Todd M. Anthony,
  Vice Pres Organizational Dev
• John M. Hamm,
  VP Chief Financial Officer